Literature DB >> 6689632

Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries.

D Opherk, G Mall, H Zebe, F Schwarz, E Weihe, J Manthey, W Kübler.   

Abstract

The pathogenesis of angina pectoris in patients with left ventricular hypertrophy secondary to arterial hypertension and with normal coronary arteries remains uncertain. We measured coronary blood flow (argon method) in 12 control subjects and in 16 patients with arterial hypertension at rest and after intravenous administration of dipyridamole (0.5 mg/kg). In the patients with arterial hypertension, coronary blood flow response to dipyridamole was markedly reduced (p less than .001 as compared with control values). During coronary vasodilation there was a linear correlation between coronary resistance and left ventricular end-diastolic pressure (r = .67, p less than .001). Left ventricular catheter biopsy specimens did not reveal alterations in myocardial microvasculature. These findings suggest that reduction of coronary reserve may be an important contributor to the pathogenesis of angina pectoris in these patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6689632     DOI: 10.1161/01.cir.69.1.1

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 2.  Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application.

Authors:  Antonio L'Abbate; Gianmario Sambuceti; Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

3.  Transthoracic Doppler echocardiographic analysis of phasic coronary blood flow velocity in hypertrophic cardiomyopathy.

Authors:  J J Crowley; P S Dardas; A A Harcombe; L M Shapiro
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

4.  [Arterial hypertension in patients with coronary artery disease].

Authors:  T Graf; H Schunkert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

Review 5.  Differences in coronary blood flow in aortic regurgitation and systemic arterial hypertension have implications for diastolic blood pressure targets: a systematic review and meta-analysis.

Authors:  Simon W Rabkin
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

6.  Coronary angiographic findings in African-American and white patients from a single institution.

Authors:  Y Liao; J K Ghali; L Berzins; R S Cooper
Journal:  J Natl Med Assoc       Date:  2001-12       Impact factor: 1.798

7.  Impaired coronary flow reserve in obstructive sleep apnea and its improvement after continuous positive airway pressure therapy: a transthoracic Doppler echocardiographic study.

Authors:  Kikuko Obase; Hiroyuki Okura; Keiji Mouri; Tomoko Maehama; Akihiro Hayashida; Nozomi Watanabe; Yoji Neishi; Takahiro Kawamoto; Mikio Oka; Kiyoshi Yoshida
Journal:  J Echocardiogr       Date:  2010-12-08

8.  Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study.

Authors:  D J Hildick-Smith; P J Johnson; C R Wisbey; E M Winter; L M Shapiro
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

9.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

10.  Loss of endothelial KATP channel-dependent, NO-mediated dilation of endocardial resistance coronary arteries in pigs with left ventricular hypertrophy.

Authors:  Marie-Eve Gendron; Eric Thorin; Louis P Perrault
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.